Contact dermatitis is a skin condition that develops as a reaction to an external substance. It’s usually not serious but can be uncomfortable. Treatment will depend on the underlying cause.

Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory familial disease of the skin. It is characterized by an increased ability to form immunoglobulin E and a tendency to ...

If the patient has reported a history of steroid use, the first treatment step should be to discontinue the medication's use immediately. However, the patient should be aware that this may result ...

There are several different kinds of eczema. The most common types are atopic dermatitis and contact dermatitis, which may appear on the stomach. Atopic (allergic) dermatitis is an autoimmune disease.

Eczema usually starts with an itch that can be a response to a trigger, such as an environmental irritant or stress. Itching that starts as a response to a trigger is called contact dermatitis. When ...

Papua New Guinea is undergoing economic and social transformation. It is one of the most diverse countries in the world; home to over 11.78 million people and more than 800 different languages spoken ...

In fact, it affects between 10 and 20 percent of children. Eczema, which is also known as atopic dermatitis, can and does persist into adulthood for more than 16 million adults. If you first ...

CAPITAL INVESTMENT BUDGET FRAMEWORK Fixed Commitments are investments that have legal or MOU/MOA or NEC Decisions Development Cooperation support remains a critical funding source to Capital ...

She also explained how important scalp care is for avoiding common scalp conditions: “A healthy scalp ensures an optimal environment for hair follicles, preventing issues like dandruff, seborrheic ...

Laurie Harmon: I live about three blocks from the train derailment, was diagnosed with systemic contact dermatitis due to chemical exposure. I have now lesions in my spine. I have cysts on my kidneys.

Furthermore, Incyte's dermatology pipeline has the potential to contribute an additional $1 billion to the top line beyond 2029, with treatments like opzelura for pediatric atopic dermatitis and ...